Brief: Biotrend Cevre Expects Consolidated Sales Revenue Around 1.1 Bln Lira - 1.3 Bln Lira For 2022
Feb 28 (Reuters) - BIOTREND CEVRE VE ENERJI YATIRIMLARI AS BIOEN.IS :
* EXPECTS CONSOLIDATED SALES REVENUE AROUND 1.1 BILLION LIRA - 1.3 BILLION
LIRA
FOR 2022
* EXPECTS INVESTMENT SPENDINGS AROUND 60%-65% OF CONSOLIDATED SALES REVENUES
IN
2022
Source text for Eikon: ID:nIKA3T8SgP
Further company coverage: BIOEN.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biotrend Cevre ve Enerji Yatirimlari
See all newsBrief: Uniper And Biotrend Plan To Tap Turkish Biomethane Potential For European Markets
Brief: Biotrend Says Subsidiary Mersin Elektrik's Capital Raised To 650 Mln Lira From 552 Mln Lira, With 98 Mln Lira Increase To Be Covered By Biotrend's Receivables From Unit
Brief: Biotrend Says It Raises Unit Nov Enerji Elektrik Uretim's Capital From 50 Mln Lira To 220 Mln Lira
Brief: Biotrend Says Unit Izmir Dogu Star's Capital Has Been Increased From 150 Mln Lira To 250 Mln Lira
Brief: Biotrend Says It Signs Additional Protocol With Izmir Metropolitan Municipality To Increase Capacity Of Bergama Integrated Solid Waste Management Plant